News Industry News CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019 September 25, 2019
News Industry News Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT October 22, 2012
News Industry News Medtronic Gets Go-Ahead from FDA for Study of Novel Treatment for High Blood Pressure July 11, 2011